Suppr超能文献

使用D-最优混合设计通过分散聚合优化新型隐形聚乳酸基纳米颗粒的制备

Optimization of the fabrication of novel stealth PLA-based nanoparticles by dispersion polymerization using D-optimal mixture design.

作者信息

Adesina Simeon K, Wight Scott A, Akala Emmanuel O

机构信息

Department of Pharmaceutical Sciences, Center for Drug Research and Development (CDRD), Howard University , Washington DC , USA and.

出版信息

Drug Dev Ind Pharm. 2014 Nov;40(11):1547-56. doi: 10.3109/03639045.2013.838578. Epub 2013 Sep 23.

Abstract

PURPOSE

Nanoparticle size is important in drug delivery. Clearance of nanoparticles by cells of the reticuloendothelial system has been reported to increase with increase in particle size. Further, nanoparticles should be small enough to avoid lung or spleen filtering effects. Endocytosis and accumulation in tumor tissue by the enhanced permeability and retention effect are also processes that are influenced by particle size. We present the results of studies designed to optimize cross-linked biodegradable stealth polymeric nanoparticles fabricated by dispersion polymerization.

METHODS

Nanoparticles were fabricated using different amounts of macromonomer, initiators, crosslinking agent and stabilizer in a dioxane/DMSO/water solvent system. Confirmation of nanoparticle formation was by scanning electron microscopy (SEM). Particle size was measured by dynamic light scattering (DLS). D-optimal mixture statistical experimental design was used for the experimental runs, followed by model generation (Scheffe polynomial) and optimization with the aid of a computer software. Model verification was done by comparing particle size data of some suggested solutions to the predicted particle sizes.

RESULTS AND CONCLUSION

Data showed that average particle sizes follow the same trend as predicted by the model. Negative terms in the model corresponding to the cross-linking agent and stabilizer indicate the important factors for minimizing particle size.

摘要

目的

纳米颗粒大小在药物递送中至关重要。据报道,随着颗粒大小增加,网状内皮系统细胞对纳米颗粒的清除作用增强。此外,纳米颗粒应足够小以避免肺部或脾脏的过滤效应。通过增强的渗透和滞留效应实现的内吞作用以及在肿瘤组织中的积累也是受颗粒大小影响的过程。我们展示了旨在优化通过分散聚合制备的交联可生物降解隐形聚合物纳米颗粒的研究结果。

方法

在二氧六环/二甲基亚砜/水溶剂体系中,使用不同量的大分子单体、引发剂、交联剂和稳定剂制备纳米颗粒。通过扫描电子显微镜(SEM)确认纳米颗粒的形成。通过动态光散射(DLS)测量颗粒大小。实验运行采用D-最优混合统计实验设计,随后生成模型(谢弗多项式)并借助计算机软件进行优化。通过将一些建议溶液的颗粒大小数据与预测颗粒大小进行比较来进行模型验证。

结果与结论

数据表明平均颗粒大小与模型预测的趋势相同。模型中与交联剂和稳定剂对应的负项表明了使颗粒大小最小化的重要因素。

相似文献

引用本文的文献

6
Drug Combinations in Breast Cancer Therapy.乳腺癌治疗中的药物联合应用
Pharm Nanotechnol. 2019;7(1):3-23. doi: 10.2174/2211738507666190122111224.

本文引用的文献

3
Has nanotechnology led to improved therapeutic outcomes?纳米技术是否提高了治疗效果?
Drug Dev Ind Pharm. 2012 Feb;38(2):158-70. doi: 10.3109/03639045.2011.597764.
10
Nanotechnology: intelligent design to treat complex disease.纳米技术:治疗复杂疾病的智能设计
Pharm Res. 2006 Jul;23(7):1417-50. doi: 10.1007/s11095-006-0284-8. Epub 2006 Jun 21.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验